Biomea Fusion Announces FDA Clearance of Investigational New Drug (IND) Application…
COVALENT-111, a Phase I/II clinical trial in patients with type 2 diabetes, already underway in Canada, will now activate sites in the USAs previously reported, the Phase I portion of…